64 Days
Source:
Financial Times
FDA panel favors peptide access despite scientist objections
A vote represents the first step toward expanding public access to the Wolverine peptide, despite concerns over potential risks.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)